Nevada, Teva Ink $193M Deal Over Opioid Crisis
Nevada will receive about $193 million from Teva Pharmaceuticals in a settlement resolving allegations that the drug company contributed to the opioid crisis by downplaying the risks of addiction, the state...To view the full article, register now.
Already a subscriber? Click here to view full article